當前位置: 首頁 » 產品 » 搜索

TAK-960 (hydrochloride)
TAK-960 hydrochloride is a novel, investigational, orally bioavailable, potent, and selective PLK1 inhibitor(IC50=1.5 nM
2016-01-04 17:08 [上海]
上海皓元生物醫(yī)藥科技有限公司 [已核實]

1300.00/5mg
05mg起訂

SNS-314
SNS-314 is a potent and selective inhibitor of Aurora A, Aurora B and Aurora C with IC50 of 9 nM, 31 nM, and 3 nM, respe
2016-01-04 17:06 [上海]
上海皓元生物醫(yī)藥科技有限公司 [已核實]

884.00/5mg
05mg起訂

CYC-116
CYC116 is a potent inhibitor of Aurora A/B with Ki of 8.0 nM/9.2 nM.IC50 Value: 8.0 nM(Aurora A); 9.2 nM(Aurora B)Target
2016-01-04 17:04 [上海]
上海皓元生物醫(yī)藥科技有限公司 [已核實]

921.00/10mg
010mg起訂

AT9283
AT9283 is a multi-targeted inhibitor with IC50s of 4, 1.2, 1.1 and approximate 3 nM for Bcr-Abl(T3151), JAK2 and JAK3, A
2016-01-04 17:02 [上海]
上海皓元生物醫(yī)藥科技有限公司 [已核實]

1252.00/5mg
05mg起訂

Alisertib
Alisertib (MLN8237) is a selective Aurora A inhibitor with IC50 of 1.2 nM; has 200-fold higher selectivity for Aurora A
2016-01-04 17:01 [上海]
上海皓元生物醫(yī)藥科技有限公司 [已核實]

884.00/5mg
05mg起訂

MK-1775
MK-1775 is a potent and selective Wee1 inhibitor with IC50 of 5.2 nM; hinders G2 DNA damage checkpoint.IC50 Value: 5.2 n
2016-01-04 16:59 [上海]
上海皓元生物醫(yī)藥科技有限公司 [已核實]

1252.00/5mg
05mg起訂

Y-33075
Y-33075 is potent and selective p160ROCK inhibitor with an Ki value of 0.14 uM,200 fold selectivity for p160ROCK than PK
2016-01-04 16:57 [上海]
上海皓元生物醫(yī)藥科技有限公司 [已核實]

2558.00/10mg
010mg起訂

GSK429286A
GSK429286A is a selective inhibitor of ROCK1 and ROCK2 with IC50 of 14 nM and 63 nM, respectively.IC50 Value: 14 nM(ROCK
2016-01-04 16:55 [上海]
上海皓元生物醫(yī)藥科技有限公司 [已核實]

1474.00/5mg
05mg起訂

BI 2536
BI2536 is a potent Plk1 inhibitor with IC50 of 0.83 nM, BI2536 shows 4- and 11-fold greater selectivity against Plk2 and
2016-01-04 16:50 [上海]
上海皓元生物醫(yī)藥科技有限公司 [已核實]

884.00/5mg
05mg起訂

GW843682X
GW843682X is a selective PLK1 and PLK3 inhibitor with IC50s of 2.2 nM(PLK1) and 9.1 nM(PLK3); displays100-fold selectivi
2016-01-04 16:48 [上海]
上海皓元生物醫(yī)藥科技有限公司 [已核實]

651.00/5mg
05mg起訂

GSK461364
GSK461364 is a potent small molecule Polo-like kinase 1 (PLK1) inhibitor with a Ki of 2.2 nM.公司介紹：專注于各種抑制劑
2016-01-04 16:47 [上海]
上海皓元生物醫(yī)藥科技有限公司 [已核實]

2800.00/10mg
010mg起訂

HY-13231
CDK9-IN-1 is a novel, selective CDK9 inhibitor for the treatment of HIV infection.IC50 value:Target: CDK9; anti HIVAmong
2016-01-04 16:45 [上海]
上海皓元生物醫(yī)藥科技有限公司 [已核實]

763.00/5mg
05mg起訂

CUDC-101
CUDC-101 is a potent multitargeted HDAC, EGFR and HER2 inhibitor with IC50 of 4.4, 2.4, and 15.7 nM, respectively.IC50 V
2016-01-04 16:42 [上海]
上海皓元生物醫(yī)藥科技有限公司 [已核實]

790.00/10mg
010mg起訂

NVP-AUY922
AUY922 (NVP-AUY922) is a highly potent HSP90 inhibitor for HSP90/ with IC50 of 13 nM /21 nM, weaker potency against the
2016-01-04 16:40 [上海]
上海皓元生物醫(yī)藥科技有限公司 [已核實]

651.00/10mg
010mg起訂

R547
R547 is a potent ATP-competitive inhibitor of CDK1/2/4 with Ki of 2 nM/3 nM/1 nM.IC50 Value: 2 nM(Ki for CDK1); 3 nM(Ki
2016-01-04 16:38 [上海]
上海皓元生物醫(yī)藥科技有限公司 [已核實]

5587.00/10mg
010mg起訂

SNS-032
SNS-032(BMS-387032) is a potent inhibitor of cyclin-dependent kinases (cdks) 9, 2 and 7 (IC50 values are 4, 38 and 62 nM
2016-01-04 16:36 [上海]
上海皓元生物醫(yī)藥科技有限公司 [已核實]

800.00/5mg
05mg起訂

PHA-793887
PHA-793887 is a novel pan-cdk inhibitor, including cdk1, cdk2, cdk4, cdk5, cdk7, and cdk9 with IC50 in the 5 to 140 nM r
2016-01-04 16:33 [上海]
上海皓元生物醫(yī)藥科技有限公司 [已核實]

1172.00/5mg
05mg起訂

Flavopiridol
Flavopiridol competes with ATP to inhibit CDKs including CDK1, CDK2, CDK4 and CDK6 with IC50 of ~ 40 nM.公司介紹：專注于
2016-01-04 16:31 [上海]
上海皓元生物醫(yī)藥科技有限公司 [已核實]

750.00/10mg
010mg起訂

AT7519
AT7519 is a multi-CDK inhibitor for CDK1, 2, 4, 6 and 9 with IC50 of 10-210 nM; less potent to CDK3 and little active to
2016-01-04 16:29 [上海]
上海皓元生物醫(yī)藥科技有限公司 [已核實]

810.00/5mg
05mg起訂

Roscovitine
Roscovitine (Seliciclib, CYC202) is a potent and selective CDK inhibitor for Cdc2, CDK2 and CDK5 with IC50 of 0.65 M, 0.
2016-01-04 16:23 [上海]
上海皓元生物醫(yī)藥科技有限公司 [已核實]